Efficacy and Safety of Certolizumab Pegol in patients with...

Efficacy and Safety of Certolizumab Pegol in patients with active Crohnʼs Disease who previously lost response or were intolerant to Infliximab: Open-Label induction results of the WELCOME Study

Vermeire, S, Abreu, M, DʼHaens, G, Colombel, J, Mitchev, K, Fedorak, R, Spehlmann, M, Lee, S, Sandborn, W, Rutgeerts, P
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
Inflammatory Bowel Diseases
DOI:
10.1097/00054725-200812003-00101
Date:
December, 2008
File:
PDF, 50 KB
english, 2008
Conversion to is in progress
Conversion to is failed